Skye Bioscience (SKYE) Non Operating Income (2012 - 2026)
Skye Bioscience (SKYE) reported Non Operating Income of $278,109 for Q2 2026, down 55.3% from $622,453 a year earlier but up 68.5% from the prior quarter.
Powered by 
Analysis
Skye Bioscience (SKYE) Non Operating Income (2012 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Skye Bioscience's Non Operating Income came in at $1.41 million, down 57.0% year-over-year; for FY2025, it was $2.24 million, down 38.3% from FY2024.
- By year, Non Operating Income came in at $3.64 million in FY2024, -$2.91 million in FY2023, -$1.16 million in FY2022 and -$672,368 in FY2021.
- Five-year quarterly Non Operating Income spans a low of -$2.07 million in Q1 2023 and a high of $1.13 million in Q1 2024.
- Year over year, Non Operating Income has now declined in each of the last four quarters, with an average decline of 42.2% over the last six quarters.
- Per Business Quant data, the three quarters before Q2 2026 came in at $165,005 (Q1 2026), $453,581 (Q4 2025) and $509,874 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 269.00 Mn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | - |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | - |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | - |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | -73.00 Mn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 387.00 Mn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | - |
| 10 | Skye Bioscience | 7.86 Mn | -80.37 Mn | - | 278,109.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 278,109.00 |
| Mar 31, 2026 | 165,005.00 |
| Dec 31, 2025 | 453,581.00 |
| Sep 30, 2025 | 509,874.00 |
| Jun 30, 2025 | 622,453.00 |
| Mar 31, 2025 | 658,243.00 |
| Dec 31, 2024 | 919,622.00 |
| Sep 30, 2024 | 1.07 Mn |
| Jun 30, 2024 | 510,826.00 |
| Mar 31, 2024 | 1.13 Mn |
| Dec 31, 2023 | -333,673.00 |
| Sep 30, 2023 | -240,068.00 |
| Jun 30, 2023 | -264,903.00 |
| Mar 31, 2023 | -2.07 Mn |
| Dec 31, 2022 | -606,972.00 |
| Sep 30, 2022 | -205,001.00 |
| Jun 30, 2022 | -195,777.00 |
| Mar 31, 2022 | -155,378.00 |
| Dec 31, 2021 | -50,650.00 |
| Sep 30, 2021 | -5,709.00 |
API Access
Skye Bioscience Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-income&ticker=SKYE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-income", "ticker": "SKYE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-income&ticker=SKYE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();